Yıldırım, VolkanOmak, M.Kara, HasanTüfekçi, M. A.2021-11-302021-11-302001-02Ozan, H. vd. (2002). "Misoprostol in labor induction". Journal of Obstetrics and Gynaecology Research, 27(1), 17-20.1341-8076https://doi.org/10.1111/j.1447-0756.2001.tb01209.xhttps://obgyn.onlinelibrary.wiley.com/doi/10.1111/j.1447-0756.2001.tb01209.xhttp://hdl.handle.net/11452/22895The efficacy of a new dosing regimen of misoprostol, a recently introduced labor-inducing agent, was studied. Fifty-eight patients received 50 mug of misoprostol intravaginally and the dose was repeated every 3 hours until uterine contractions begin. Those who had an adequate contraction pattern, defined as three contractions in 10 minutes, were not given the repeat dose. Oxytocin augmentation, but not further misoprostol doses, was used in patients with an inadequate contraction pattern. The maximum total daily dose was 200 mug. The patients had the mean age of 28.9 +/- 5.4, the mean gestational age of 211.8 +/- 46.6 days, the mean gravidity of 2.5 +/- 1.2, the mean parity of 0.9 +/- 0.9 and the mean initial Bishop score of 1.6 +/- 1.8. The mean required dose of misoprostol was 120.5 +/- 54.7 mug and 10 of 58 patients required oxytocin augmentation. The mean induction of labor to delivery time was 701.5 +/- 404.0 minutes. When 3 cases who gave birth with caesarean section were excluded, the interval was 708.4 +/- 407.2 minutes. The mean 5th minute Apgar score of the newborns was 8.2 +/- 2.5. Two patients developed tachysystole after the second dose of misoprostol and were managed with vaginal irrigation and 02 supplementation successfully. Slight nausea and vomiting in 2 patients were the other adverse reactions. Our findings revealed that, 50 mug intravaginal misoprostol, combined with oxytocin augmentation when necessary, appears to be an effective and safe method of labor inductioneninfo:eu-repo/semantics/openAccessCervical ripeningLabor inductionMisoprostolProstaglandin E(2) gelIntravaginal misoprostolObstetrics & gynecologyArticle0001733335000022-s2.0-0035083408172027111330725Obstetrics & gynecologyInduced Labor; Cervical Ripening; MisoprostolClinical trialMisoprostolOxytocinApgar scoreArticleCesarean sectionDose responseCost effectiveness analysisDeliveryDrug costDrug efficacyDrug mechanismDrug safetyDrug tolerabilityFemaleOxygen therapyHeart arrhythmiaHumanNausea and vomiting